Back to Agenda
Regulatory Affairs: Part 5: The NDA – New Drug Application
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Regulatory Affairs: Part 5: The NDA – New Drug Application
Have an account?